PYPD
PolyPid Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$5.39
+2.28%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 18.40x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 20.32x
- Price / sales
- —
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $104.5M
- EV / sales
- —
- EV / EBITDA
- -3.40x
- EV / EBIT
- 89.77x
- Market cap
- $109.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026